USA - NASDAQ:HSDT - US42328V8761 - Common Stock
The current stock price of HSDT is 5.42 USD. In the past month the price decreased by -62.58%. In the past year, price decreased by -98.71%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.16 | 218.48B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.75 | 202.94B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.97 | 148.51B | ||
| SYK | STRYKER CORP | 26.78 | 134.84B | ||
| IDXX | IDEXX LABORATORIES INC | 55.78 | 56.27B | ||
| BDX | BECTON DICKINSON AND CO | 12.43 | 51.37B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.44 | 48.95B | ||
| RMD | RESMED INC | 25.22 | 36.43B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.85 | 33.21B | ||
| PODD | INSULET CORP | 70.16 | 22.57B | ||
| DXCM | DEXCOM INC | 29.77 | 21.71B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.85 | 17.39B |
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
SOLANA CO
642 Newtown Yardley Road
Newtown PENNSYLVANIA 18940 US
CEO: Dane C. Andreeff
Employees: 21
Phone: 12159446100
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
The current stock price of HSDT is 5.42 USD. The price decreased by -1.45% in the last trading session.
HSDT does not pay a dividend.
HSDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
SOLANA CO (HSDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1969.73).
The Revenue of SOLANA CO (HSDT) is expected to decline by -20.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
SOLANA CO (HSDT) will report earnings on 2025-11-10, after the market close.
ChartMill assigns a fundamental rating of 3 / 10 to HSDT. While HSDT has a great health rating, there are worries on its profitability.
Over the last trailing twelve months HSDT reported a non-GAAP Earnings per Share(EPS) of -1969.73. The EPS decreased by -212.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -269.67% | ||
| ROE | -353.22% | ||
| Debt/Equity | 0 |
For the next year, analysts expect an EPS growth of 87.29% and a revenue growth -20.09% for HSDT